Xenon Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.31 |
7.42 |
19.56 |
87.58 |
362.67 |
712.93 |
| Przychód Δ r/r |
0.00% |
2273.33% |
163.76% |
347.72% |
314.08% |
96.58% |
| Przychód (min) |
0.30 |
7.20 |
19.56 |
87.58 |
352.18 |
692.32 |
| Przychód (max) |
0.31 |
7.47 |
19.56 |
87.59 |
365.39 |
718.28 |
| EBITDA (średnia) |
-0.05 |
-1.29 |
-3.40 |
-15.23 |
-63.06 |
-123.97 |
| EBIT (średnia) |
-0.06 |
-1.32 |
-3.48 |
-15.58 |
-64.51 |
-126.82 |
| EBIT % |
-17.79% |
-17.79% |
-17.79% |
-17.79% |
-17.79% |
-17.79% |
| Zysk netto (średni) |
-251.45 |
-312.90 |
-388.86 |
-406.96 |
-166.52 |
96.35 |
| Zysk netto % |
-80462.72% |
-4218.83% |
-1987.84% |
-464.65% |
-45.92% |
13.51% |
| EPS (średnia) |
-3.10 |
-4.02 |
-4.39 |
-4.46 |
-2.14 |
1.24 |
| Liczba analityków (Przychody) |
11 |
9 |
17 |
16 |
14 |
15 |
| Liczba analityków (EPS) |
12 |
12 |
15 |
13 |
9 |
11 |
| symbol |
XENE |
XENE |
XENE |
XENE |
XENE |
XENE |